Literature DB >> 33137360

Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma.

Junfeng Wang1, Yongchun Wang1, Yifan Chu1, Zhixiong Li1, Xingjuan Yu1, Zhijie Huang1, Jing Xu1, Limin Zheng2.   

Abstract

BACKGROUND & AIMS: Macrophages (Mϕ) represent a major component of tumor tissues and play an important role in both tumor progression and therapeutic response. Although tumor Mϕ are generally considered to be derived from circulating monocytes, emerging evidence indicates that tissue Mϕ pools can be maintained by self-renewal. We aimed to elucidate the contribution, phenotype, and regulatory mechanisms of proliferating Mϕ in human hepatocellular carcinoma (HCC).
METHODS: Flow cytometry analyses were performed to examine the presence and phenotype of proliferating Mϕ in fresh HCC tissues. Dual immunofluorescence staining was applied to analyze the prognostic value of proliferating Mϕ. The underlying regulatory mechanisms were examined using human monocyte-derived Mϕ.
RESULTS: Tumor-infiltrating Mϕ exhibited a significantly higher proliferative capacity than Mϕ in non-tumor tissues. A higher level of Mϕ proliferation was positively correlated with Mϕ density in the tumor and a poor prognosis in patients with HCC. Proliferating Mϕ were less differentiated (with increased CD206 expression) and were induced by the tumor cell-derived soluble small molecule, adenosine, but not proteins, lipids, or large peptides. Mechanistic studies demonstrated that autocrine granulocyte-macrophage colony-stimulating factor (GM-CSF) released by tumor-stimulated Mϕ could enhance A2A receptor expression on Mϕ and function synergistically with adenosine to elicit Mϕ proliferation in HCC.
CONCLUSIONS: Local Mϕ proliferation is an important mechanism for Mϕ accumulation in HCC tissues. Tumor-derived adenosine functions synergistically with autocrine GM-CSF released from activated Mϕ, which promotes Mϕ proliferation. Thus, selective modulation of Mϕ accumulation at the source may provide a novel strategy for cancer therapy. LAY
SUMMARY: Tumor-associated macrophages (TAMs) have been reported to play an essential role in both tumor progression and therapeutic response. A fundamental understanding of the mechanisms that regulate macrophage accumulation in tumors will undoubtedly lead to the development of strategies to target macrophages with high specificity and efficiency. The current study unveils a novel mechanism by which local proliferation is linked to macrophage accumulation in the tumor milieu, identifying potential targets for future immune-based anticancer therapies.
Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenosine; Hepatocellular carcinoma; Mϕ proliferation

Mesh:

Substances:

Year:  2020        PMID: 33137360     DOI: 10.1016/j.jhep.2020.10.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  14 in total

Review 1.  The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis.

Authors:  Xingxing Zhang; Wenxiu Bai; Lisha Hu; Hualan Ha; Yuelin Du; Wei Xiong; Hongbo Wang; Panfeng Shang
Journal:  Clin Transl Oncol       Date:  2022-09-07       Impact factor: 3.340

Review 2.  Targeting tumor-associated macrophages for cancer treatment.

Authors:  Mengjun Li; Linye He; Jing Zhu; Peng Zhang; Shufang Liang
Journal:  Cell Biosci       Date:  2022-06-07       Impact factor: 9.584

Review 3.  Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting.

Authors:  Tetiana Hourani; James A Holden; Wenyi Li; Jason C Lenzo; Sara Hadjigol; Neil M O'Brien-Simpson
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

4.  ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma.

Authors:  Xiaoxi Ouyang; Longxian Lv; Yalei Zhao; Fen Zhang; Qingqing Hu; Zuhong Li; Danhua Zhu; Lanjuan Li
Journal:  Front Oncol       Date:  2022-01-11       Impact factor: 6.244

Review 5.  The Metabolic Control of Myeloid Cells in the Tumor Microenvironment.

Authors:  Eloise Ramel; Sebastian Lillo; Boutaina Daher; Marina Fioleau; Thomas Daubon; Maya Saleh
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

Review 6.  Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.

Authors:  Zuzanna Sas; Ewa Cendrowicz; Isabel Weinhäuser; Tomasz P Rygiel
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

7.  Metabolism drives macrophage heterogeneity in the tumor microenvironment.

Authors:  Shasha Li; Jiali Yu; Amanda Huber; Ilona Kryczek; Zhuwen Wang; Long Jiang; Xiong Li; Wan Du; Gaopeng Li; Shuang Wei; Linda Vatan; Wojciech Szeliga; Arul M Chinnaiyan; Michael D Green; Marcin Cieslik; Weiping Zou
Journal:  Cell Rep       Date:  2022-04-05       Impact factor: 9.995

Review 8.  Programmed Cell Death Tunes Tumor Immunity.

Authors:  Jing Liu; Minjing Hong; Yijia Li; Dan Chen; Yangzhe Wu; Yi Hu
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

9.  Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.

Authors:  Narjes Saheb Sharif-Askari; Fatemeh Saheb Sharif-Askari; Bushra Mdkhana; Saba Al Heialy; Elaref Ratemi; Malak Alghamdi; Salah Abusnana; Tarek Kashour; Qutayba Hamid; Rabih Halwani
Journal:  Arch Toxicol       Date:  2020-08-17       Impact factor: 5.153

Review 10.  Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers.

Authors:  Deyang Wu; Xiaowei Liu; Jingtian Mu; Jin Yang; Fanglong Wu; Hongmei Zhou
Journal:  Biomolecules       Date:  2022-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.